Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.156 CHF
88.82 M CHF
406.13 M CHF
90.20 M
About Corcept Therapeutics Incorporated
Sector
CEO
Joseph K. Belanoff
Headquarters
Redwood City
Website
Founded
1998
FIGI
BBG00LVD6673
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HTD is 46.754 CHF — it has decreased by −22.07% in the past 24 hours. Watch CORCEPT THERAPEUTI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange CORCEPT THERAPEUTI stocks are traded under the ticker HTD.
HTD stock hasn't changed in a week, the last month showed zero change in price, over the last year CORCEPT THERAPEUTI has showed a 112.01% increase.
We've gathered analysts' opinions on CORCEPT THERAPEUTI future price: according to them, HTD price has a max estimate of 69.13 CHF and a min estimate of 57.89 CHF. Watch HTD chart and read a more detailed CORCEPT THERAPEUTI stock forecast: see what analysts think of CORCEPT THERAPEUTI and suggest that you do with its stocks.
HTD stock is 52.83% volatile and has beta coefficient of 1.94. Track CORCEPT THERAPEUTI stock price on the chart and check out the list of the most volatile stocks — is CORCEPT THERAPEUTI there?
Today CORCEPT THERAPEUTI has the market capitalization of 4.80 B, it has increased by 7.17% over the last week.
Yes, you can track CORCEPT THERAPEUTI financials in yearly and quarterly reports right on TradingView.
CORCEPT THERAPEUTI is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
HTD earnings for the last quarter are 0.35 CHF per share, whereas the estimation was 0.24 CHF resulting in a 45.42% surprise. The estimated earnings for the next quarter are 0.33 CHF per share. See more details about CORCEPT THERAPEUTI earnings.
CORCEPT THERAPEUTI revenue for the last quarter amounts to 154.69 M CHF, despite the estimated figure of 145.73 M CHF. In the next quarter, revenue is expected to reach 174.94 M CHF.
HTD net income for the last quarter is 39.57 M CHF, while the quarter before that showed 31.57 M CHF of net income which accounts for 25.31% change. Track more CORCEPT THERAPEUTI financial stats to get the full picture.
No, HTD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 19, 2024, the company has 352.00 employees. See our rating of the largest employees — is CORCEPT THERAPEUTI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CORCEPT THERAPEUTI EBITDA is 122.71 M CHF, and current EBITDA margin is 22.46%. See more stats in CORCEPT THERAPEUTI financial statements.
Like other stocks, HTD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORCEPT THERAPEUTI stock right from TradingView charts — choose your broker and connect to your account.